Federal Health Grants

This funding opportunity provides financial support to organizations in U.S. territories and freely associated states to implement strategies that prevent and control chronic diseases, focusing on tobacco use, diabetes management, and oral health disparities.

This funding opportunity supports postdoctoral researchers transitioning to independent faculty positions in biomedical sciences, providing financial assistance to help them establish their own research programs.

The purpose of the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00) is to increase and maintain a strong cohort of new and talented independent investigators conducting research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions

This funding opportunity provides financial support to organizations that offer mentoring services to children and youth affected by opioid and other substance use, helping them and their families through structured programs and supportive services.

This funding opportunity is designed to support collaborative research projects that investigate the long-term neurological effects of adolescent alcohol consumption on brain development and behavior in adulthood, inviting a wide range of eligible applicants from various sectors.

This funding opportunity provides financial support for early-stage researchers transitioning to independent careers in clinical and translational science, enabling them to conduct small-scale research projects that can lead to larger studies.

This funding opportunity supports the development of innovative tools and technologies aimed at advancing research and treatment in kidney, urologic, and hematologic diseases, encouraging projects that push scientific boundaries and have broad applications beyond individual research interests.

This program provides funding to interdisciplinary teams developing automated tools to ensure the accuracy and reliability of AI models used in healthcare, addressing performance degradation and enhancing patient safety.

This funding opportunity provides financial support to eligible local and state governments, tribes, and nonprofit organizations for cleaning up contaminated properties they own, helping to revitalize communities affected by pollution and disinvestment.

The Patient-Centered Outcomes and Survivorship Award supports high-risk, high-reward research studies that span the spectrum of behavioral health science, survivorship, health outcomes and comparative effectiveness research, including quality of life, symptom and side effect management, resilience, co-morbid conditions, and examining the physical, psychological, social, and economic effects of lung cancer among patients and their families.The overall intent of the FY24 LCRP Patient-Centered Outcomes and Survivorship Award is to promote evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research studies may include, but are not limited to:Studies to examine and improve quality of life, decision-making, and symptom and side effect management (e.g., toxicity of treatment, palliative/supportive care, psychological distress and anxiety).Studies to investigate the impact of prevention, diagnostics, treatment, or health care delivery approaches on health outcomes.Studies to assess the relationship(s) between behavioral, cognitive, and/or social functioning in relation to lung cancer detection, initiation, progression, treatment, and rehabilitation.Studies into the psychological health and well-being of those affected by lung cancer (e.g., patients, family members).Development and testing for efficacy of lifestyle interventions and symptom management approaches to minimize disease risk and maximize quality of life.Key aspects of this award mechanism are:Impact: The Patient-Centered Outcomes and Survivorship Award is intended to support research that demonstrates the potential to have a major impact on patient outcomes. Research should challenge paradigms with respect to impact on patient care and outcomes. Proposed projects may include translational or clinical research, including pilot clinical trials. Impactful research will accelerate the movement of promising ideas into clinical applications, generate knowledge to improve clinical guidelines, or significantly advance behavioral, cognitive, and/or social functioning related to the target population.Study Design: Applications should clearly articulate the chosen design of the study. Basic studies should demonstrate research strategy, feasibility, and how the study relates to the human experience with lung cancer. Studies entailing retrospective or prospective recruitment should define the type of architecture of the study (e.g., descriptive, correlational, field experimental, meta-analyses). Study populations should be defined. The rationale should support the chosen study design with statistical evaluation to back the design. Questionnaires should be described in sufficient detail to justify interpretation of potential results.Preliminary Data: The Patient-Centered Outcomes and Survivorship Award requires preliminary data for all studies that propose the active (prospective) recruitment of human subjects. Studies not proposing active recruitment of human subjects are not required to present preliminary data but should be supported by sound reasoning and relevant literature.Patient Advocate Participation: Applications to the Patient-Centered Outcomes and Survivorship Award funding opportunity are encouraged to include a patient advocate. As part of the research team, the patient advocate would assist in the development of the research question, project design, oversight, recruitment, and evaluation, as well as other significant aspects of the proposed project. The patient advocate will be a person with a history of lung cancer diagnosis. As a lay representative, the patient advocate should be active in a cancer advocacy organization. Interactions with other team members should be well integrated and ongoing, not limited to attending seminars and semi-annual meetings. The role of the patient advocate should be focused on providing objective input on the research and its potential impact for individuals with or at risk for lung cancer.

This funding opportunity supports small businesses in developing innovative medical devices specifically designed to help children and adolescents struggling with substance use and addiction.

The purpose of this program is to assist applicants in establishing goals and performance measures, assess their current management capacity, and determine if Public Health Department development is practicable. Specifically, programs should assess the availability and applicability of the 10 Essential Public Health Services (EPHS).The 10 EPHS include:1. Assess and monitor population health status, factors that influence health, and community needs and assets.2. Investigate, diagnose, and address health problems and hazards affecting the population.3. Communicate effectively to inform and educate people about health, factors that influence it, and how to improve it.4. Strengthen, support, and mobilize communities and partnerships to improve health.5. Create, champion, and implement policies, plans, and laws that impact health.6. Use legal and regulatory actions designed to improve and protect the publics health.7. Contribute to an effective system that enables equitable access to the individual services and care needed to be healthy.8. Build and support a diverse and skilled public health workforce.9. Improve and innovate public health functions through ongoing evaluation, research, and continuous quality improvement.10. Build and maintain a strong organizational infrastructure for public health.

This funding opportunity provides long-term financial support to experienced cancer researchers who are pursuing innovative and high-risk projects that could lead to significant advancements in cancer science.

This grant provides funding for researchers to explore how the human microbiome influences immune responses to prevent cancer, aiming to identify new strategies for cancer prevention.

This funding opportunity supports research into innovative non-invasive brain stimulation techniques to treat substance use disorders, targeting under-explored brain areas and measuring treatment success indicators.

This funding opportunity supports research institutions and organizations in developing new drugs to prevent, slow, or treat Alzheimer's disease through early-stage and preclinical studies.

This funding opportunity supports projects that promote inclusive economic growth and human development in Equatorial Guinea, encouraging collaboration between local and U.S. organizations, individuals, and educational institutions.

This funding opportunity provides financial support to state and local governments, nonprofit organizations, and educational institutions to improve the collection and use of health data, particularly focusing on addressing health disparities in underserved communities across the U.S.

This grant provides funding for U.S.-based institutions to conduct economic research and develop tools that improve interventions for substance use disorder within the criminal-legal system, ultimately aiming to reduce overdose risks.

The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications on chronic conditions understudied among women and/or that disproportionately affect populations of women who are understudied, underrepresented, and underreported in biomedical Research should align with Goal 1 of the 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women." The awards under this FOA will be administered by NIH ICs using funds that have been made available through the Office of Research on Womens Health (ORWH) and the scientific partnering Institutes and Centers across NIH.